Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 209 of 5804
-
Magic mushroom therapy could help heal trauma from domestic abuse
Symptom relief Not yet recruitingThe goal of this randomized controlled trial is to evaluate the efficacy of psilocybin administered with Acceptance and Commitment Therapy (ACT) as an intervention to reduce post-traumatic stress disorder (PTSD) symptom burden in adult (aged 18-65) survivors of intimate partner v…
Phase: PHASE2 • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Creatine may shield breast cancer patients from 'Chemo Brain'
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether oral creatine supplementation can prevent chemotherapy-related cognitive impairment in patients with early-stage breast cancer undergoing neoadjuvant or adjuvant chemotherapy. The main questions it aims to answer are: * Does…
Phase: PHASE3 • Sponsor: D'Or Institute for Research and Education • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Experimental vaccine cocktail targets rare liver cancer in early trial
Disease control Not yet recruitingThe purpose of this study is to determine whether the combination of a neoantigen vaccine targeting the DNAJB1-PRKACA fusion kinase in combination with DRP-104, Nivolumab and Ipilimumab is safe and yields a clinically compelling antitumor activity measured as based on objective r…
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Progesterone pill may stop dangerous pregnancy condition
Prevention Not yet recruitingThis randomized controlled trial evaluates whether nightly vaginal micronized progesterone (400 mg) initiated before 12 weeks' gestation reduces the incidence of preeclampsia in low-risk pregnant individuals. Participants will be randomly assigned (1:1) to receive either vaginal …
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Could a common diabetes drug help fight a deadly lung disease?
Disease control Not yet recruitingThis is a randomized, placebo-controlled trial of metformin in 400 participants with idiopathic pulmonary fibrosis (IPF) who are at high risk of adverse clinical outcomes based on a proteomic classifier. The primary objective is to assess the safety and efficacy of metformin comp…
Phase: PHASE3 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Brain zaps tailored to you: new hope for PTSD?
Symptom relief Not yet recruitingThis study is testing a personalized form of brain stimulation called PrTMS as a treatment for post-traumatic stress disorder (PTSD) in military service members and veterans. Unlike standard approaches, this treatment uses a simple brainwave test (EEG) to tailor the therapy to ea…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New hope for Hard-to-Treat prostate cancer: drug combo trial launches
Disease control Not yet recruitingThe purpose of this study is to find out whether mevrometostat in combination with enzalutamide delays cancer progression in people with metastatic castration-resistant prostate cancer (mCRPC) who have previously received enzalutamide, darolutamide, or apalutamide in the metastat…
Phase: PHASE2 • Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New hope for Hard-to-Treat ovarian cancer: drug combo trial launches
Disease control Not yet recruitingThe purpose of this clinical trial is to assess the safety and efficacy of ubamatamab in combination with first-line chemotherapy in patients with ovarian cancer. The main questions it aims to answer are: * What is the safety profile of ubamatamab when administered with carbopla…
Phase: PHASE1, PHASE2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Mind over matter: brain implant could restore digital independence for quadriplegics
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate control of digital devices through a brain implant in people with spinal cord injury. The main question it aims to answer is efficient, independent, BCI-based control over digital devices in settings of daily living of an individu…
Phase: NA • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a schizophrenia drug curb Cocaine's grip?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Cobenfy influences the effects of cocaine in people with cocaine use disorder. This trial will also provide information about the safety and tolerability of combining Cobenfy and cocaine. Researchers will compare Cobenfy to a placeb…
Phase: PHASE1, PHASE2 • Sponsor: Joshua A. Lile, Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a 4-session talk therapy prevent PTSD after a burn injury?
Prevention Not yet recruitingThe purpose of this clinical trial is to adapt and test a brief patient-caregiver early intervention designed to reduce posttraumatic stress symptoms in hospitalized burn patients and their caregivers. This intervention is a brief, 4-session cognitive-behavioral intervention desi…
Phase: NA • Sponsor: University of Southern California • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Sound and sight training may restore vision after stroke
Disease control Not yet recruitingDamage to visual cortex on one side of the brain frequently produces a profound and permanent blindness in contralesional space (hemianopia), a debilitating condition that causes enormous suffering for patients and their families.
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New radiation technique aims to shield airways and preserve lung function
Symptom relief Not yet recruitingDecreased respiratory function is a common side effect experienced by non-small cell lung cancer (NSCLC) patients who receive radiation therapy. In current clinical practice when treating cancerous lesions in the lung, it is not standard to explicitly try and avoid excessive radi…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
AI reads brain tumor types from routine slides, no special stains needed
Knowledge-focused Not yet recruitingThis is a multi-center, retrospective, observational study to develop and internally validate an artificial intelligence (AI) foundation model for hierarchical classification of central nervous system (CNS) tumors using approximately 20,000 hematoxylin and eosin (H\&E) whole-slid…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo aims to shield Children's hearts from kawasaki disease
Disease control Not yet recruitingThis study evaluates the efficacy and safety of the addition of Firsekibart to standard initial treatment (intravenous immunoglobulin \[IVIG\] plus aspirin) in children with Acute Kawasaki Disease (KD) .
Phase: PHASE2, PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Artificial intelligence could help prevent transplant complications by personalizing drug dosing
Disease control Not yet recruitingThe purpose of this study is to develop a new tool that helps doctors choose the right cyclosporine dose for patients undergoing bone marrow transplantation. The tool is designed to predict the best dose using sparse sampling, making it practical for everyday clinical care. It co…
Sponsor: Yasmin medhat munir Mohamed • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Herbal formula may help HIV patients whose immune systems Don't fully recover
Disease control Not yet recruitingThis pragmatic randomized controlled trial evaluates whether Qiling Yiqi Tablets combined with antiretroviral therapy (ART) improves immune reconstitution in people with HIV who meet criteria for immune reconstitution failure and lung-spleen qi deficiency syndrome. Eligible parti…
Phase: NA • Sponsor: Beijing University of Chinese Medicine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Brain wave decoding aims to shield memory during tumor surgery
Disease control Not yet recruitingBrain tumors and their surgical treatment may impair cognitive function, affecting patients' quality of life. This prospective single-arm study aims to evaluate the feasibility and clinical utility of an EEG-based neural signal decoding strategy for cognitive function preservatio…
Phase: NA • Sponsor: Bo Wang • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a daily pill shield transplant patients from a common virus?
Prevention Not yet recruitingThe purpose of this clinical trial is to find out whether a medication, called letermovir, can help prevent a virus called cytomegalovirus (CMV) in participants who receive a kidney or liver transplant and who have already been exposed the CMV. Participants will take letermovir …
Phase: PHASE4 • Sponsor: University of Wisconsin, Madison • Aim: Prevention
Last updated Jul 17, 2026 00:00 UTC
-
Can a targeted pill boost Chemo's power against a rare blood cancer?
Disease control Not yet recruitingThis is a single-arm, multicenter, Phase Ib/IIa study designed to explore the efficacy and safety of SHR2554 in combination with liposomal mitoxantrone for the treatment of patients with treatment-naive peripheral T-cell lymphoma (PTCL). The study is divided into a Phase Ib safet…
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC